World Vaccine Congress Washington 2010
Apr 19,2010 - Apr 22,2010Westfields Marriott Washington Dulles, Chantilly, Virginia, United States
-
Highlights
Now in its 10th year, World Vaccine Congress 2010 remains the industry’s definitive vaccine industry event for major vaccine players and their respective senior level representatives.
Key issues to be addressed
* How is government drawing parallels between Health Care reform, public health preparedness and vaccines?
* How will priority setting in the National Vaccine Plan impact future industry vaccine programmes
* How are Big Pharma strategising future vaccine research and commercialisation efforts?
* How are non-traditional "BRIC" markets helping shape a truly globalised vaccine industry?
* How are Federal and industry approaches to H1N1 meeting demand? What is still required?
* How are the big 7 vaccine markets shaping up? Where are there still opportunities for growth?
* How can industry secure long-term expansion through emerging market presence and partners?
* How can traditional intra-market strategic collaborations offer up novel and complimentary growth?
* How can vaccine approval and licensure be obtained in an ever evolving regulatory framework?
* How are technological advances impacting R&D and advancing product development timelines?

Event Reminder
- Registration Open
- Call for Papers
- Call for Speakers
- Receive GTM eblast updates
- Security Code:
Event Profile
- Sponsors: PPD, Sanofi Pasteur, Millipore, BD, CSL Biotheraphies
- Speakers: Dr Daniel Adams (Chief Executive Officer, Protein Sciences), Dr Jeffrey Almond (Vice President, Discovery and External Research and Development, Sanofi Pasteur), Ms Marty Anderson (Director, Project Management, i3 Research)
Contact Details
- Contact person: Gina Geldenhuys
- Event website: http://www.terrapinn.com/2010/wvcdc/index.stm
- Phone: 0044 (0) 207 827 5997
- Fax: 0044 (0) 207 242 150
Tags
Contact Organizer











